Lindbrook Capital’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $696K | Buy |
6,897
+1,186
| +21% | +$120K | 0.06% | 173 |
|
2024
Q4 | $510K | Buy |
5,711
+94
| +2% | +$8.4K | 0.05% | 215 |
|
2024
Q3 | $471K | Sell |
5,617
-32
| -0.6% | -$2.68K | 0.04% | 225 |
|
2024
Q2 | $435K | Sell |
5,649
-144
| -2% | -$11.1K | 0.04% | 227 |
|
2024
Q1 | $397K | Buy |
5,793
+182
| +3% | +$12.5K | 0.04% | 242 |
|
2023
Q4 | $324K | Buy |
5,611
+1,924
| +52% | +$111K | 0.03% | 260 |
|
2023
Q3 | $195K | Buy |
3,687
+211
| +6% | +$11.1K | 0.02% | 321 |
|
2023
Q2 | $188K | Buy |
3,476
+1
| +0% | +$54 | 0.02% | 337 |
|
2023
Q1 | $174K | Buy |
3,475
+1,442
| +71% | +$72.1K | 0.02% | 345 |
|
2022
Q4 | $94.1K | Sell |
2,033
-9,966
| -83% | -$461K | 0.01% | 505 |
|
2022
Q3 | $465K | Buy |
11,999
+321
| +3% | +$12.4K | 0.08% | 151 |
|
2022
Q2 | $435K | Buy |
11,678
+119
| +1% | +$4.43K | 0.07% | 168 |
|
2022
Q1 | $512K | Sell |
11,559
-180
| -2% | -$7.97K | 0.08% | 158 |
|
2021
Q4 | $499K | Buy |
11,739
+80
| +0.7% | +$3.4K | 0.08% | 166 |
|
2021
Q3 | $506K | Buy |
11,659
+8
| +0.1% | +$347 | 0.13% | 67 |
|
2021
Q2 | $498K | Buy |
11,651
+35
| +0.3% | +$1.5K | 0.11% | 79 |
|
2021
Q1 | $449K | Buy |
11,616
+263
| +2% | +$10.2K | 0.1% | 79 |
|
2020
Q4 | $408K | Buy |
11,353
+16
| +0.1% | +$575 | 0.1% | 84 |
|
2020
Q3 | $433K | Buy |
11,337
+42
| +0.4% | +$1.6K | 0.12% | 67 |
|
2020
Q2 | $397K | Sell |
11,295
-313
| -3% | -$11K | 0.12% | 71 |
|
2020
Q1 | $379K | Sell |
11,608
-863
| -7% | -$28.2K | 0.14% | 59 |
|
2019
Q4 | $564K | Sell |
12,471
-55
| -0.4% | -$2.49K | 0.2% | 50 |
|
2019
Q3 | $510K | Buy |
12,526
+123
| +1% | +$5.01K | 0.19% | 48 |
|
2019
Q2 | $533K | Buy |
12,403
+45
| +0.4% | +$1.93K | 0.21% | 47 |
|
2019
Q1 | $474K | Buy |
12,358
+99
| +0.8% | +$3.8K | 0.19% | 51 |
|
2018
Q4 | $433K | Buy |
+12,259
| New | +$433K | 0.21% | 49 |
|